PMC7336721 1. Pulmonary Edema in COVID19-A Neural Hypothesis.
32614178
PMC7340758 2. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.
32638079
3. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.
32628642
PMC7340586 4. Eicosanoids: the Overlooked Storm in COVID-19?
32650004
PMC7332909 5. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.
32628931
6. DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY.
32639866
PMC7322478 7. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.
32622243
PMC7327214 8. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.
32611313
PMC7332942 9. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters.
32629042
10. Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.
32646930
11. Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.
32645391
PMC7347255 12. Adrenomedullin in COVID-19 induced endotheliitis.
32646523
13. Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.
32643351
PMC7331527 14. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.
32640417
15. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers.
32610564
PMC7332957 16. Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms.
32646736
PMC7338277 17. Reappearance of effector T cells is associated with recovery from COVID-19.
32650275
PMC7332440 18. Illuminating COVID-19 lung disease through autopsy studies.
32629393
PMC7320257 19. Eosinopenia and COVID-19 patients: So specific ?
32632419
20. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
32633718
21. Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.
32614767
22. High neutralizing antibody titer in intensive care unit patients with COVID-19.
32618497
PMC7337795 23. Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.
32620946
PMC7324339 24. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
32615182
PMC7334944 25. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.
32634438
PMC7338400 26. JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk.
32631841
PMC7338404 27. Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19.
32631838
PMC7338399 28. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?
32631836
29. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts.
32646049
30. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
32646047
PMC7336935 31. Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.
32645523
PMC7335631 32. SARS-CoV2 envelope protein: Non-synonymous mutations and its consequences.
32640274
PMC7275846 33. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.
32641873
PMC7332842 34. Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic.
32621172
PMC7324922 35. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.
32615316
PMC7327474 36. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
32622082
PMC7340733 37. A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.
32638151
PMC7334931 38. Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.
32634585
PMC7327488 39. SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns.
32613447
40. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.
32630032
41. Putative Roles for Peptidylarginine Deiminases in COVID-19.
32629995
42. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.
32645951
43. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.
32640747
PMC7332849 44. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models.
32621017
PMC7341709 45. Serum antibody response in critically ill patients with COVID-19.
32642784
PMC7331543 46. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
32624257
PMC7323673 47. Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak.
32615258
48. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
32639084
49. Kinetics of viral load and antibody response in relation to COVID-19 severity.
32634129
50. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.
32610587
51. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.
32635302
PMC7336919 52. Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients.
32645361
PMC7323671 53. SARS-CoV-2 detection, viral load and infectivity over the course of an infection.
32615199
PMC7330586 54. Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.
32622905
PMC7337834 55. Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study.
32614392
PMC7344352 56. Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents.
32647285
PMC7336130 57. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.
32645344
PMC7333600 58. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?
32645661
PMC7332450 59. Is macrophages heterogeneity important in determining COVID-19 lethality?
32645660
PMC7330590 60. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
32650197
PMC7329669 61. Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection.
32645659
62. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel.
32646911
63. Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing.
32646908
PMC7343781 64. Immunological and inflammatory profiles in mild and severe cases of COVID-19.
32641700
PMC7340775 65. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.
32641705
PMC7343905 66. Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic.
32648040
PMC7343579 67. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.
32642842
{{tp|p=32614178|t=2020. Pulmonary Edema in COVID19-A Neural Hypothesis.|pdf=|usr=}}
{{tp|p=32638079|t=2020. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.|pdf=|usr=}}
{{tp|p=32628642|t=2020. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.|pdf=|usr=}}
{{tp|p=32650004|t=2020. Eicosanoids: the Overlooked Storm in COVID-19?|pdf=|usr=}}
{{tp|p=32628931|t=2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.|pdf=|usr=}}
{{tp|p=32639866|t=2020. DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY.|pdf=|usr=}}
{{tp|p=32622243|t=2020. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.|pdf=|usr=}}
{{tp|p=32611313|t=2020. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.|pdf=|usr=}}
{{tp|p=32629042|t=2020. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters.|pdf=|usr=}}
{{tp|p=32646930|t=2020. Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.|pdf=|usr=}}
{{tp|p=32645391|t=2020. Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.|pdf=|usr=}}
{{tp|p=32646523|t=2020. Adrenomedullin in COVID-19 induced endotheliitis.|pdf=|usr=}}
{{tp|p=32643351|t=2020. Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.|pdf=|usr=}}
{{tp|p=32640417|t=2020. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.|pdf=|usr=}}
{{tp|p=32610564|t=2020. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers.|pdf=|usr=}}
{{tp|p=32646736|t=2020. Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms.|pdf=|usr=}}
{{tp|p=32650275|t=2020. Reappearance of effector T cells is associated with recovery from COVID-19.|pdf=|usr=}}
{{tp|p=32629393|t=2020. Illuminating COVID-19 lung disease through autopsy studies.|pdf=|usr=}}
{{tp|p=32632419|t=2020. Eosinopenia and COVID-19 patients: So specific ?|pdf=|usr=}}
{{tp|p=32633718|t=2020. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.|pdf=|usr=}}
{{tp|p=32614767|t=2020. Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.|pdf=|usr=}}
{{tp|p=32618497|t=2020. High neutralizing antibody titer in intensive care unit patients with COVID-19.|pdf=|usr=}}
{{tp|p=32620946|t=2020. Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.|pdf=|usr=}}
{{tp|p=32615182|t=2020. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.|pdf=|usr=}}
{{tp|p=32634438|t=2020. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.|pdf=|usr=}}
{{tp|p=32631841|t=2020. JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk.|pdf=|usr=}}
{{tp|p=32631838|t=2020. Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19.|pdf=|usr=}}
{{tp|p=32631836|t=2020. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?|pdf=|usr=}}
{{tp|p=32646049|t=2020. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts.|pdf=|usr=}}
{{tp|p=32646047|t=2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.|pdf=|usr=}}
{{tp|p=32645523|t=2020. Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.|pdf=|usr=}}
{{tp|p=32640274|t=2020. SARS-CoV2 envelope protein: Non-synonymous mutations and its consequences.|pdf=|usr=}}
{{tp|p=32641873|t=2020. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.|pdf=|usr=}}
{{tp|p=32621172|t=2020. Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic.|pdf=|usr=}}
{{tp|p=32615316|t=2020. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.|pdf=|usr=}}
{{tp|p=32622082|t=2020. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.|pdf=|usr=}}
{{tp|p=32638151|t=2020. A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.|pdf=|usr=}}
{{tp|p=32634585|t=2020. Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.|pdf=|usr=}}
{{tp|p=32613447|t=2020. SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns.|pdf=|usr=}}
{{tp|p=32630032|t=2020. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.|pdf=|usr=}}
{{tp|p=32629995|t=2020. Putative Roles for Peptidylarginine Deiminases in COVID-19.|pdf=|usr=}}
{{tp|p=32645951|t=2020. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.|pdf=|usr=}}
{{tp|p=32640747|t=2020. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.|pdf=|usr=}}
{{tp|p=32621017|t=2020. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models.|pdf=|usr=}}
{{tp|p=32642784|t=2020. Serum antibody response in critically ill patients with COVID-19.|pdf=|usr=}}
{{tp|p=32624257|t=2020. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.|pdf=|usr=}}
{{tp|p=32615258|t=2020. Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak.|pdf=|usr=}}
{{tp|p=32639084|t=2020. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32634129|t=2020. Kinetics of viral load and antibody response in relation to COVID-19 severity.|pdf=|usr=}}
{{tp|p=32610587|t=2020. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.|pdf=|usr=}}
{{tp|p=32635302|t=2020. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.|pdf=|usr=}}
{{tp|p=32645361|t=2020. Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients.|pdf=|usr=}}
{{tp|p=32615199|t=2020. SARS-CoV-2 detection, viral load and infectivity over the course of an infection.|pdf=|usr=}}
{{tp|p=32622905|t=2020. Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.|pdf=|usr=}}
{{tp|p=32614392|t=2020. Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study.|pdf=|usr=}}
{{tp|p=32647285|t=2020. Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents.|pdf=|usr=}}
{{tp|p=32645344|t=2020. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.|pdf=|usr=}}
{{tp|p=32645661|t=2020. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?|pdf=|usr=}}
{{tp|p=32645660|t=2020. Is macrophages heterogeneity important in determining COVID-19 lethality?|pdf=|usr=}}
{{tp|p=32650197|t=2020. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.|pdf=|usr=}}
{{tp|p=32645659|t=2020. Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection.|pdf=|usr=}}
{{tp|p=32646911|t=2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel.|pdf=|usr=}}
{{tp|p=32646908|t=2020. Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing.|pdf=|usr=}}
{{tp|p=32641700|t=2020. Immunological and inflammatory profiles in mild and severe cases of COVID-19.|pdf=|usr=}}
{{tp|p=32641705|t=2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.|pdf=|usr=}}
{{tp|p=32648040|t=2020. Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic.|pdf=|usr=}}
{{tp|p=32642842|t=2020. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.|pdf=|usr=}}
68. Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms.
32627524
69. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.
32650002
70. COVID-ARDS Clarified: A Vascular Endotype?
32631071
71. RV Infections in Asthmatics Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19.
32649217
72. COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury.
32608999
73. Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study.
32628534
74. Covid-19 related IgA vasculitis.
32633104
75. Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain.
32636189
76. Tackling COVID-19 infection through complement-targeted immunotherapy.
32643798
77. Potential impact of SARS-CoV-2 infection on the thymus.
32640169
78. Reply to the letter concerning Kawasaki Disease and Covid-19.
32641195
79. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
32638018
80. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
32636454
81. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.
32639942
82. The early antibody response to SARS-Cov-2 infection.
32639941
83. Direct evidence of active SARS-CoV-2 replication in the intestine.
32638022
84. Microbiota and Covid-19. Which came first, the chicken or the egg?
32645713
85. Angiotensin II Receptors - Impact for COVID-19 Severity.
32645228
86. COVID-19: Yin and Yang and Herd Immunity.
32631463
87. Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases.
32645207
88. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32635753
89. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.
32614086
90. Inflammatory Cell Infiltration of Adrenals in COVID-19.
32629518
91. SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats.
32643416
92. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.
32615317
93. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.
32624498
94. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.
32643586
95. The Inter-alpha-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.
32639183
96. BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.
32640487
97. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.
32644266
98. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.
32644223
99. Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: Report of two cases.
32639581
100. The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).
32633840
101. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.
32633815
102. Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection.
32642770
103. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran.
32640066
104. Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
32641486
105. Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?
32622377
106. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.
32611256
107. Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.
32640127
108. A COVID-19 model.
32641847
109. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.
32647358
110. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
32647346
111. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
32616673
112. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.
32638509
{{tp|p=32627524|t=2020. Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms.|pdf=|usr=}}
{{tp|p=32650002|t=2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.|pdf=|usr=}}
{{tp|p=32631071|t=2020. COVID-ARDS Clarified: A Vascular Endotype?|pdf=|usr=}}
{{tp|p=32649217|t=2020. RV Infections in Asthmatics Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19.|pdf=|usr=}}
{{tp|p=32608999|t=2020. COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury.|pdf=|usr=}}
{{tp|p=32628534|t=2020. Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study.|pdf=|usr=}}
{{tp|p=32633104|t=2020. Covid-19 related IgA vasculitis.|pdf=|usr=}}
{{tp|p=32636189|t=2020. Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain.|pdf=|usr=}}
{{tp|p=32643798|t=2020. Tackling COVID-19 infection through complement-targeted immunotherapy.|pdf=|usr=}}
{{tp|p=32640169|t=2020. Potential impact of SARS-CoV-2 infection on the thymus.|pdf=|usr=}}
{{tp|p=32641195|t=2020. Reply to the letter concerning Kawasaki Disease and Covid-19.|pdf=|usr=}}
{{tp|p=32638018|t=2020. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.|pdf=|usr=}}
{{tp|p=32636454|t=2020. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.|pdf=|usr=}}
{{tp|p=32639942|t=2020. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.|pdf=|usr=}}
{{tp|p=32639941|t=2020. The early antibody response to SARS-Cov-2 infection.|pdf=|usr=}}
{{tp|p=32638022|t=2020. Direct evidence of active SARS-CoV-2 replication in the intestine.|pdf=|usr=}}
{{tp|p=32645713|t=2020. Microbiota and Covid-19. Which came first, the chicken or the egg?|pdf=|usr=}}
{{tp|p=32645228|t=2020. Angiotensin II Receptors - Impact for COVID-19 Severity.|pdf=|usr=}}
{{tp|p=32631463|t=2020. COVID-19: Yin and Yang and Herd Immunity.|pdf=|usr=}}
{{tp|p=32645207|t=2020. Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases.|pdf=|usr=}}
{{tp|p=32635753|t=2020. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=}}
{{tp|p=32614086|t=2020. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.|pdf=|usr=}}
{{tp|p=32629518|t=2020. Inflammatory Cell Infiltration of Adrenals in COVID-19.|pdf=|usr=}}
{{tp|p=32643416|t=2020. SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats.|pdf=|usr=}}
{{tp|p=32615317|t=2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.|pdf=|usr=}}
{{tp|p=32624498|t=2020. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.|pdf=|usr=}}
{{tp|p=32643586|t=2020. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.|pdf=|usr=}}
{{tp|p=32639183|t=2020. The Inter-alpha-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.|pdf=|usr=}}
{{tp|p=32640487|t=2020. BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.|pdf=|usr=}}
{{tp|p=32644266|t=2020. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32644223|t=2020. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.|pdf=|usr=}}
{{tp|p=32639581|t=2020. Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: Report of two cases.|pdf=|usr=}}
{{tp|p=32633840|t=2020. The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).|pdf=|usr=}}
{{tp|p=32633815|t=2020. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.|pdf=|usr=}}
{{tp|p=32642770|t=2020. Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=32640066|t=2020. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran.|pdf=|usr=}}
{{tp|p=32641486|t=2020. Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.|pdf=|usr=}}
{{tp|p=32622377|t=2020. Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?|pdf=|usr=}}
{{tp|p=32611256|t=2020. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.|pdf=|usr=}}
{{tp|p=32640127|t=2020. Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.|pdf=|usr=}}
{{tp|p=32641847|t=2020. A COVID-19 model.|pdf=|usr=}}
{{tp|p=32647358|t=2020. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.|pdf=|usr=}}
{{tp|p=32647346|t=2020. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.|pdf=|usr=}}
{{tp|p=32616673|t=2020. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.|pdf=|usr=}}
{{tp|p=32638509|t=2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.|pdf=|usr=}}
